ATOSSA THERAPEUTICS, INC. Other Non-Current Assets
ATOSSA THERAPEUTICS, INC. (ATOS) had Other Non-Current Assets of $1.27 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-07
- 2026-06-30: Other Assets, Noncurrent $1.27M.
- 2026-03-31: Other Assets, Noncurrent $1.27M.
- 2025-12-31: Other Assets, Noncurrent $1.99M.
- 2025-09-30: Other Assets, Noncurrent $2.33M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $1.27M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $1.27M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.99M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $2.33M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.00M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $2.00M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.99M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $2.37M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.43M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $2.32M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $2.32M 10-K · filed 2025-03-25 | |
| 2023-09-30 | $2.34M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $642.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $631.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $635.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $629.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $627.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $630.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $22.00K 10-K · filed 2023-03-22 | $2.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $13.41K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $13.41K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $16.47K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $17.00K 10-K · filed 2022-02-28 | $17.22K 10-K · filed 2021-03-31 |
| 2020-09-30 | $17.22K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $17.22K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $17.22K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $17.22K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $17.22K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $17.22K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $17.22K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $17.22K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $88.52K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $48.87K 10-Q/A · filed 2018-11-13 | |
| 2018-03-31 | $114.57K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $178.91K 10-K · filed 2019-03-28 | |
| 2017-09-30 | $108.72K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $128.58K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $148.57K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $194.25K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $227.88K 10-Q/A · filed 2017-03-21 | |
| 2016-06-30 | $268.38K 10-Q/A · filed 2017-03-21 | |
| 2016-03-31 | $76.34K 10-Q/A · filed 2017-03-21 | |
| 2015-12-31 | $76.34K 10-K/A · filed 2017-03-21 | |
| 2015-09-30 | $52.65K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $52.65K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $176.55K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $48.19K 10-K · filed 2016-03-30 | |
| 2014-03-31 | $4.55M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $36.45K 10-K · filed 2015-03-30 | $4.43M 10-K · filed 2014-03-27 |
| 2013-09-30 | $4.44M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $4.49M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $4.60M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $4.68M 10-K · filed 2014-03-27 | |
| 2012-09-30 | $4.74M 10-Q/A · filed 2013-01-22 | |
| 2011-12-31 | $46.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |